Volume 28, Number 6—June 2022
CME ACTIVITY - Synopsis
Cross-Sectional Study of Clinical Predictors of Coccidioidomycosis, Arizona, USA
Table 1
Characteristics |
Positive, n = 73 |
Negative, n = 319 |
Total, n = 392 |
p value |
---|---|---|---|---|
Median age, y (range) |
55 (18–83) |
57 (18–98) |
57 (18–98) |
0.038 |
Sex, no. (%) | 0.514 | |||
F | 38 (52.8) | 152 (47.9) | 190 (48.8) | |
M |
34 (47.2) |
165 (52.1) |
199 (51.2) |
|
Race, no. (%) | 0.024 | |||
African American | 8 (11.4) | 18 (5.8) | 26 (6.8) | |
American Indian/Alaska Native | 6 (8.6) | 11 (3.5) | 17 (4.5) | |
Asian | 3 (4.3) | 4 (1.3) | 7 (1.8) | |
White | 52 (74.3) | 263 (84.8) | 315 (82.9) | |
Unknown |
1 (1.4) |
14 (4.5) |
15 (3.9) |
|
Ethnicity, no. (%) | 0.882 | |||
Hispanic | 18 (26.5) | 87 (28.1) | 105 (27.8) | |
Non-Hispanic |
50 (73.5) |
223 (71.9) |
273 (72.2) |
|
Median length of endemic residence, y (range) |
13 (0–78) |
21 (0–98) |
20 (0–98) |
0.017 |
Admission status, no. (%) | ||||
Outpatient | 31 (42.5) | 49 (15.4) | 80 (20.5) | <0.001 |
Inpatient |
42 (57.5) |
269 (84.6) |
311 (79.5) |
|
Immunocompromised, no. (%) | 0.001 | |||
Y | 24 (33.3) | 174 (55.1) | 198 (51) | |
N | 48 (66.7) | 142 (44.9) | 190 (49) | |
*Bold text indicates statistical significance.
Page created: March 21, 2022
Page updated: May 20, 2022
Page reviewed: May 20, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.